Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
type: MedicalStudy
description: A Phase II Multicenter Trial to Assess the Safety and Efficacy of Campath-1H and Tacrolimus Followed By Immunosuppression Withdrawal in Liver Transplantation (ITN024ST)
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2005-06
end date: 2011-03
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00105235
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
study subject: Liver Disease
study subject: Liver Transplantation
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Liver Disease
keywords: Liver Transplantation

AI Analytics
type: Organization